Leinco Technologies Launches AI-Powered “Leinco Antibody Advisor” to Support Researcher Success
St. Louis, MO — [October 17, 2025] — Leinco Technologies, a leading provider of high-quality antibodies and recombinant proteins, is proud to announce the launch of its new AI-powered tool, the Leinco Antibody Advisor. This [...]
Leinco Technologies Forms Scientific Advisory Board to Advance Biomedical Innovation
Renowned Experts Dr. Robert Schreiber and Dr. Garry Nolan Join as Inaugural Members St. Louis, MO — September 29th, 2025 — Leinco Technologies, a leader in antibody and protein development, is pleased to announce the formation [...]
Leinco Technologies Acquires BioClin, Inc.’s Essential IVD Raw Material Antibody Clones, Bolstering Leinco’s IVD Raw Material Catalog Business
Saint Louis, MO – July 7, 2025 Leinco Technologies, a leading global provider of in vitro diagnostic (IVD) raw materials, today announced the acquisition of BioClin, Inc.’s proprietary antibody clones used as IVD raw materials. [...]
Message from Leinco Technologies: Antibody Pricing Stability Amid Market Shifts
St. Louis, MO, 17 June, 2025 - Leinco Technologies remains committed to supporting the global scientific community by ensuring consistent access to high-quality recombinant antibodies and reagents—without unexpected price increases. As tariffs and international trade [...]
Leinco Technologies Launches Groundbreaking ADAPT-3D™ Tissue Clearing Kit to Accelerate 3D Fluorescence Imaging
St. Louis, MO, 25 April, 2025 - Leinco Technologies, a leading innovator in life science research and diagnostic solutions, is proud to announce the launch of its ADAPT-3D Tissue Clearing Kit. This new offering is [...]
Leinco Technologies Awarded $1M Grant to Develop Rapid Test for Intestinal Immunity to Polio
St. Louis, MO, February 6, 2025 - Leinco Technologies, a leader in antibody and protein development, is thrilled to announce that it has been awarded a $1M grant from the Gates Foundation. The grant aims [...]
